© Copyright 2003 Frost & Sullivan. All Rights Reserved. Strategic Assessment of Oncology Research and Opportunities in the Asia Pacific Biotech Markets Biotech Drugs with Better Specificity to Push out Conventional Treatment Strategies Discovery and Diagnostics Group “Globally, biotech-related oncology research is marching ahead with nearly 700 drugs in development and over 1800 research projects dedicated to studying the disease.”

© Copyright 2003 Frost & Sullivan. All Rights Reserved. Industry Trends Lung, breast, and prostate cancers and non-Hodgkin’s lymphoma are the various types of cancers in which extensive biotechnology research is being conducted across the world Developments in the areas of genomics and proteomics have helped biotech-related oncology research immensely Earlier, countries in the Asia Pacific did not focus on basic research in the field of oncology. With the focus on basic research driving the development of applied research, the Asia Pacific region is far behind the United States and European countries in oncology research and development

© Copyright 2003 Frost & Sullivan. All Rights Reserved. Industry Trends (Cont’d) Globally, developments in biotech-based oncology treatments are gaining with the success enjoyed by monoclonal antibodies as a treatment strategy The increase in general awareness among patients as well as physicians about the disease and available treatment strategies has opened up the untapped market in Asia Pacific. With governments taking strong initiatives to develop respective countries into hubs of research activities in biotechnology, oncology research will also gain greater attention

© Copyright 2003 Frost & Sullivan. All Rights Reserved. Key Features Frost & Sullivan Provides: Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analyst insights on ‘hot topics’ and emerging applications in the Asia Pacific biotech-related oncology research market Market sizing and competitive analysis Market forecasts and opportunity analysis End-user analysis within each report

© Copyright 2003 Frost & Sullivan. All Rights Reserved. What We Offer Global Coverage: U.S., Europe, Japan, and Asia Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Winning strategies to help you create precise business plans

© Copyright 2003 Frost & Sullivan. All Rights Reserved. Who Will Benefit? Current Market Participants  Find out how you compare to the competition  Assess current and future drivers and restraints  Determine and exploit new market share opportunities New Entrants  Analyze challenges associated with the industry  Calculate time scales for strategy implementation  Position yourself to capitalize on the market’s unmet needs Investment Community  Analyze long-term strategies of Asia Pacific biotech companies  Determine which participants will outperform the competition  Assess attractiveness of investing in Asia Pacific biotech research

© Copyright 2003 Frost & Sullivan. All Rights Reserved. What’s Included Oncology research - Current treatment strategies - Key challenges - Biotech-related oncology research Overview of the global biotech-related oncology research, focus areas of research, and industry participants Overview of the Asia Pacific biotech-related oncology research, focus area of research, and industry participants Asia Pacific market analysis - Predictive opportunities model and opportunity mapping for biotech-related oncology research in the Asia Pacific Markets Growth strategies for the Asia Pacific biotech-related oncology research participants and new entrants

© Copyright 2003 Frost & Sullivan. All Rights Reserved.  Call toll free: 877 GO FROST ( )  Fax toll free:   Visit: For More Information